Interleukin-23R rs7517847 T/G Polymorphism Contributes to the Risk of Crohn’s Disease in Caucasians: A Meta-Analysis

Table 2

Stratified analysis of rs7517847 polymorphism and CD risk in eligible studies.

Author	Year	T versus G allele	TT versus GG; OR (95% CI)	TG versus GG; OR (95% CI)	TT + TG versus GG; (95% CI)	TT versus TG + GG; (95% CI)
Total		1.327 (1.198, 1.469)	1.890 (1.465, 2.437)	1.509 (1.161, 1.960)	1.652 (1.277, 2.137)	1.409 (1.279, 1.552)
Safrany et al. [13]	2013	1.357 (1.036, 1.777)	2.347 (1.223, 4.503)	1.922 (1.036, 3.568)	2.070 (1.137, 3.769)	1.371 (0.923, 2.038)
Szabo et al. [14]	2013	1.102 (0.856, 1.419)	1.069 (0.618, 1.850)	0.747 (0.445, 1.253)	0.865 (0.528, 1.417)	1.337 (0.921, 1.942)
Ferguson et al. [15]	2010	1.349 (1.084, 1.678)	2.373 (1.432, 3.933)	2.334 (1.446, 3.766)	2.349 (1.481, 3.724)	1.213 (0.879, 1.673)
Lauriola et al. [16]	2011	0.344 (0.126, 0.941)	0.115 (0.012, 1.129)	0.111 (0.009, 1.309)	0.114 (0.012, 1.062)	0.485 (0.134, 1.754)
Lacher et al. [17]	2010	1.176 (0.908, 1.523)	1.331 (0.790, 2.243)	1.036 (0.632, 1.698)	1.149 (0.723, 1.828)	1.298 (0.886, 1.902)
Latiano et al. [18]	2008	1.553 (1.328, 1.816)	2.715 (1.884, 3.913)	1.931 (1.340, 2.784)	2.292 (1.618, 3.248)	1.596 (1.295, 1.968)
Márquez et al. [19]	2008	1.347 (1.104, 1.643)	1.972 (1.269, 3.063)	1.617 (1.050, 2.489)	1.768 (1.172, 2.665)	1.357 (1.029, 1.791)
Baptista et al. [20]	2008	1.045 (0.793, 1.377)	1.147 (0.640, 2.055)	1.216 (0.704, 2.100)	1.188 (0.706, 2.000)	0.990 (0.656, 1.492)
Newman et al. [21]	2009	1.542 (1.302, 1.827)	2.665 (1.805, 3.935)	1.918 (1.307, 2.815)	2.223 (1.541, 3.207)	1.598 (1.265, 2.019)
Okazaki et al. [22]	2008	1.355 (1.054, 1.741)	1.692 (1.024, 2.798)	1.918 (1.307, 2.815)	1.294 (0.825, 2.029)	1.621 (1.122, 2.342)
Oliver et al. [23]	2007	1.515 (1.187, 1.935)	3.153 (1.761, 5.648)	2.938 (1.658, 5.207)	3.033 (1.752, 5.252)	1.347 (0.959, 1.891)